Skip to main content

Reliance Global Group Inc

For the period ended Mar 31, 2024. Filed May 20, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 20, 2024

EZRA$2.61+23.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Financial Statements

Reliance Global Group, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

March 31,December 31,
20242023
Assets
Current assets:
Cash$680,138$1,329,016
Restricted cash1,432,8471,409,895
Accounts receivable1,020,8791,298,863
Accounts receivable, related parties6,5126,603
Other receivables29,498899
Prepaid expense and other current assets240,780333,756
Total current assets3,410,6544,379,032
Property and equipment, net144,723139,999
Right-of-use assets653,524739,830
Intangibles, net6,611,21511,042,757
Goodwill6,693,0996,693,099
Other non-current assets21,79220,292
Total assets$17,535,007$23,015,009
Current liabilities:
Accounts payable and other accrued liabilities$1,180,328$835,483
Short term financing agreements11,60156,197
Current portion of loans payables, related parties626,676454,953
Other payables23,8097,414
Current portion of long-term debt1,431,8751,390,766
Current portion of leases payable256,340285,171
Earn-out liability, current portion-159,867
Total current liabilities3,530,6293,189,851
Loans payable, related parties, less current portion780,915897,529
Long term debt, less current portion10,660,32111,026,971
Leases payable, less current portion427,972484,335
Warrant liabilities173,660268,993
Total liabilities15,573,49715,867,679
Stockholders’ equity:
Preferred stock, $0.086 par value; 750,000,000 shares authorized and 9,076 and 0 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively--
Common stock, $0.086 par value; 2,000,000,000 shares authorized and 5,692,387 and 4,761,974 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively489,525409,509
Additional paid-in capital45,820,61345,739,786
Accumulated deficit(44,348,628)(39,001,965)
Total stockholders’ equity1,961,5107,147,330
Total liabilities and stockholders’ equity$17,535,007$23,015,009

Condensed Consolidated Statements of Operations

Three Months ended · Three Months ended
March 31, 2024 · March 31, 2023
Revenue
Commission income$4,082,438$3,939,103
Total revenue4,082,4383,939,103
Operating expenses
Commission expense1,276,5421,083,326
Salaries and wages1,831,6621,755,894
General and administrative expenses1,374,890837,766
Marketing and advertising127,042136,571
Change in estimated acquisition earn-out payables47,761476,692
Depreciation and amortization534,152653,778
Asset impairments3,922,110-
Total operating expenses9,114,1594,944,027
Loss from operations(5,031,721)(1,004,924)
Other (expense) income
Interest expense(369,677)(351,823)
Interest expense, related parties(40,609)(41,477)
Other income, net113,949
Recognition and change in fair value of warrant liabilities95,3334,266,231
Total other (expense) income(314,942)3,876,880
(Loss) income from continuing operations before tax(5,346,663)2,871,956
Income (loss) from discontinued operations before tax-(4,660,494)
Net loss$(5,346,663)$(1,788,538)
Basic (loss) earnings per share
Continuing operations$(0.81)$1.92
Discontinued operations$-$(3.07)
Basic (loss) earnings per share$(0.81)$(1.15)
Diluted loss per share
Continuing operations$(0.81)$(0.59)
Discontinued operations$-$(2.18)
Diluted loss per share$(0.81)$(2.77)
Weighted average number of shares outstanding - basic6,569,0191,553,953
Weighted average number of shares outstanding - diluted6,569,0192,185,847

Condensed Consolidated Statements of Stockholders’ Equity

Common stock · Additional paid-in · Accumulated
SharesAmountcapitaldeficitTotal
Balance, December 31, 20234,761,974$409,509$45,739,786$(39,001,965)$7,147,330
Common share payments forearn-outs--17,628-17,628
Common shares issued for ATM share sales187,61416,135108,514-124,649
Common shares issued for Abeyance Share conversions723,26462,201(62,201)--
Common share based compensation19,5351,68016,88618,566
Net loss---(5,346,663)(5,346,663)
Balance, March 31, 20245,692,387$489,525$45,820,613$(44,348,628)$1,961,510
Common stock · Additional paid-in · Accumulated
SharesAmountcapitaldeficitTotal
Balance, December 31, 20221,219,573$104,883$35,798,139$(26,991,983)$8,911,039
Common shares issued for earn-out liabilities109,3589,404973,074-982,478
Common shares issued to settle loan - Yes Americana66,7435,740639,260-645,000
Round up of Common shares due to reverse split15,3361,300(5,946)-(4,646)
Common shares issued in 2023 private placement155,03813,3333,433,151-3,446,484
Common share based compensation--43,797-43,797
Net loss---(1,788,538)(1,788,538)
Balance, March 31, 20231,566,048$134,660$40,881,475$(28,780,521)$12,235,614

Reliance Global Group, Inc. and Subsidiaries and Predecessor

Condensed Consolidated Statements of Cash Flows

For the 3 months ended March 31,
20242023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income$(5,346,663)$(1,788,538)
Adjustment to reconcile net income to net cash used in operating activities:
Depreciation and amortization534,152541,873
Asset impairments3,922,110-
Amortization of debt issuance costs and accretion of debt discount11,72111,721
Non-cash lease expense (income)1,110(5,098)
Equity based compensation expense18,56643,797
Recognition and change in fair value of warrant liability(95,333)(4,266,231)
Earn-out fair value and write-off adjustments47,761476,692
Change in operating assets and liabilities:
Accounts receivable277,98423,976
Accounts receivable, related parties916,676
Other receivables(28,599)11,464
Prepaid expense and other current assets92,97681,381
Other non-current assets(1,500)-
Accounts payables and other accrued liabilities344,847125,229
Other payables16,395(294,058)
Net cash used in continuing operating activities(204,382)(5,031,116)
Net cash adjustments for discontinued operating activities-3,966,238
Total net cash used in continuing and discontinued operating activities(204,382)(1,064,878)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment(12,312)(6,695)
Purchase of intangibles(17,132)(73,894)
Net cash used in investing activities(29,444)(80,589)
Net cash used in discontinued investing activities-(15,708)
Total net cash used in continuing and discontinued investing activities(29,444)(96,297)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal repayments of debt(335,533)(207,580)
Proceeds of loans payable related parties-345,000
Principal repayments of short term financings(44,596)(98,004)
Payments of loans payable, related parties(136,620)(412,500)
Proceeds from common shares issued through an at the market offering124,649-
Cash payments on earn-out liability-(250,000)
Private Placement of shares and warrants-3,446,484
Net cash used in and provided by continuing financing activities(392,100)2,823,400
Net cash used in discontinued financing activities-(17,700)
Total net cash (used in) and provided by continuing and discontinued financing activities(392,100)2,805,700
Net (decrease) and increase in cash and restricted cash(625,926)1,644,525
Cash and restricted cash at beginning of year2,738,9111,909,769
Cash and restricted cash at end of year$2,112,985$3,554,294

Notes to the Unaudited Condensed Consolidated Financial Statements

NOTE 1. SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

Reliance Global Group, Inc., formerly known as Ethos Media Network, Inc. (“RELI”, “Reliance”, or the “Company”), was incorporated in Florida on August 2, 2013.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”), as the same may be amended from time to time. Capitalized terms not defined in this Form 10-Q refer to capitalized terms as defined in the Form 10-K. Certain prior period accounts and balances in these condensed consolidated financial statements and notes thereto have been reclassified to conform to the current period’s presentation.

The accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Liquidity

As of March 31, 2024, the Company’s reported cash and restricted cash aggregated balance was approximately $2,113,000, current assets were approximately $3,411,000, while current liabilities were approximately $3,531,000. As of March 31, 2024, the Company had a working capital deficit of approximately $120,000 and stockholders’ equity of approximately $1,962,000. For the three months ended March 31, 2024, the Company presents loss from operations of approximately $5,032,000, which includes a non-cash asset impairment loss of approximately $3,900,000, and net loss of approximately $5,347,000. During the first quarter of 2024 the Company entered into an At Market Issuance Sales Agreement (the “ATM Agreement”) to which the Company may offer and sell, from time to time through the Agent, shares of its Common Stock (the “Shares”), having an aggregate offering price of up to $858,637.

Although there can be no assurance that debt or equity financing will be available on acceptable terms, the Company believes its financial position and its ability to raise capital to be reasonable and sufficient. Based on our assessment, we do not believe there are conditions or events that, in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year of filing these financial statements with the Securities and Exchange Commission (“SEC”).

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.

Cash and Restricted Cash

Cash and restricted cash reported on our condensed consolidated balance sheets are reconciled to the total shown on our condensed consolidated statements of cash flows as follows:

March 31, 2024March 31, 2023
Cash$680,138$2,116,333
Restricted cash1,432,8471,437,961
Total cash and restricted cash$2,112,985$3,554,294

Fair Value of Financial Instruments

Level 1 — Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;

Level 2 — Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability; and

Level 3 — Unobservable inputs for the asset or liability, which include management’s own assumption about the assumptions market participants would use in pricing the asset or liability, including assumptions about risk.

**Warrant Liabilities:**The Company re-measures the fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option pricing model. The following summarizes the significant unobservable inputs:

March 31, 2024December 31, 2023
Stock price$0.34$0.54
Volatility135.00%110.00%
Time to expiry4.744.99
Dividend yield0%0%
Risk free rate4.20%3.80%

The following reconciles fair value of the liability classified warrants:

Series B warrant liabilitiesPlacement agent warrantsTotal
Beginning balance, December 31, 2022$6,384,250$48,900$6,433,150
Unrealized (gain) loss(5,534,931)(48,575)(5,583,506)
Warrants exercised or exchanged(580,651)-(580,651)
Ending balance, December 31, 2023$268,668$325$268,993
Unrealized (gain) loss(95,333)-(95,333)
Warrants exercised or exchanged---
Ending balance, March 31, 2024$173,335$325$173,660

Earn-out liabilities: The Company utilizes two valuation methods to value its Level 3 earn-out liabilities, a) the income valuation approach and b) the Monte Carlo simulation method. Key valuation and unobservable inputs for the income valuation approach include contingent payment arrangement terms, projected revenues and cash flows, rates of return, discount rates and probability assessments.

The following table reconciles fair value of earn-out liabilities for the periods ended March 31, 2024, and December 31, 2023:

March 31, 2024 · December 31, 2023
Beginning balance – January 1$159,867$2,709,478
Acquisitions and settlements-(3,260,403)
Period adjustments:
Fair value changes included in earnings*47,7611,716,873
Earn-out payable in common shares(17,628)(159,867)
Earn-out transferred to loans payable, related parties(190,000)(846,214)
Ending balance-159,867
Less: Current portion-(159,867)
Ending balance, less current portion$-$-
*Recorded in the change in estimated acquisition earn-out payables caption on the condensed consolidated statements of operations.

Revenue Recognition

The following table disaggregates the Company’s revenue by line of business, showing commissions earned:

Three Months ended March 31, 2024 · Medical · Life · Property and Casualty · Total
EBS$229,004$3,700$-$232,704
USBA9,758750-10,508
CCS/UIS--27,94827,948
Montana442,9541,209-444,163
Fortman292,1881,782228,815522,785
Altruis2,028,2256,351-2,034,576
Kush193,807--193,807
Reli Exchange78,04342,425495,479615,947
Total$3,273,979$56,217$752,242$4,082,438
Three Months ended March 31, 2023 · Medical · Life · Property and Casualty · Total
EBS$233,280$4,100$-$237,380
USBA11,265764-12,029
CCS/UIS--46,77046,770
Montana486,0094,985-490,994
Fortman305,877393208,145514,415
Altruis1,868,136--1,868,136
Kush320,175116-320,291
Reli Exchange71,37023,381354,337449,088
Total$3,296,112$33,739$609,252$3,939,103

The following are customers representing 10% or more of total revenue:

Three Months ended March 31,
Insurance Carrier20242023
Priority Health45%43%
BlueCross BlueShield13%13%

No other single customer accounted for more than 10% of the Company’s commission revenues during the three months ended March 31, 2024 and 2023. The loss of any significant customer could have a material adverse effect on the Company. Customers from 2022 were adjusted to reflect percentages of revenue from continued operations.

Income Taxes

The Company recordedno income tax expense for the three months ended March 31, 2024 and 2023 because the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.

As of March 31, 2024 and December 31, 2023, the Company provided a full valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.

Recently Issued Accounting Pronouncements

We do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.

NOTE 2. GOODWILL AND OTHER INTANGIBLE ASSETS

The following table rolls forward the Company’s goodwill balance for the periods ended March 31, 2024, and December 31, 2023, adjusted for discontinued operations.

Goodwill
December 31, 2022$14,287,099
Goodwill impairment recognized as of December 31, 2023(7,594,000)
December 31, 20236,693,099
March 31, 2024$6,693,099

Asset Impairments:

During the quarter ended March 31, 2024, certain intangible assets stemming from discontinued operations which were originally transferred to the Company’s operating entity, were determined to have carrying values exceeding fair value, and thus were considered impaired. These intangible assets consisted of, customer relationships, and internally developed and purchased software, with respective net of accumulated amortization asset values of, $3,802,438, $65,411, and $54,261. The write-offs resulted in a total asset impairment charge of $3,922,110, recorded in the asset impairment account on the condensed consolidated statements of operations for the three-month period ended March 31, 2024.

The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of March 31, 2024:

Weighted Average Remaining Amortization Period (Years)Gross Carrying AmountAccumulated AmortizationNet Carrying Amount
Trade name and trademarks1.3$1,807,188$(1,408,895)$398,292
Internally developed software3.01,694,186(686,798)1,007,388
Customer relationships6.57,372,290(2,629,691)4,742,599
Purchased software2.2564,396(562,844)1,552
Video production assets-50,000(50,000)-
Non-competition agreements0.63,504,810(3,043,426)461,384
$14,992,869$(8,381,654)$6,611,215

The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2023:

Weighted Average Remaining Amortization period (Years)Gross Carrying AmountAccumulated AmortizationNet Carrying Amount
Trade name and trademarks1.5$1,807,189$(1,320,939)$486,250
Internally developed software3.21,798,922(650,029)1,148,893
Customer relationships8.011,922,290(3,193,629)8,728,661
Purchased software0.3667,206(618,418)48,788
Video Production Assets-50,000(50,000)-
Non-competition agreements0.93,504,810(2,874,645)630,165
Trade name and trademarks$19,750,417$(8,707,660)$11,042,757

The following table reflects expected amortization expense as of March 31, 2024, for each of the following five years and thereafter:

Years ending December 31,Amortization Expense
2024 (remainder of year)$1,225,917
20251,395,707
20261,146,882
2027807,363
2028717,314
Thereafter1,318,032
Total$6,611,215

NOTE 3. LONG-TERM DEBT AND SHORT-TERM FINANCINGS

Long-Term Debt

The composition of the long-term debt follows:

March 31, 2024December 31, 2023
Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, variable interest of Prime Rate plus 2.5%, maturing August 2028, net of deferred financing costs of $9,614 and $10,069 as of March 31, 2024 and December 31, 2023, respectively$354,376$369,602
Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, variable interest of Prime Rate plus 1.5%, maturing December 2028, net of deferred financing costs of $11,887 and $12,525 as of March 31, 2024 and December 31, 2023, respectively581,392604,830
Oak Street Funding LLC Term Loan for the acquisition of SWMT, variable interest of Prime Rate plus 2.0%, maturing April 2029, net of deferred financing costs of $7,365 and $7,733 as of March 31, 2024 and December 31, 2023, respectively671,220695,758
Oak Street Funding LLC Term Loan for the acquisition of FIS, variable interest of Prime Rate plus 2.0%, maturing May 2029, net of deferred financing costs of $29,572 and $31,026 as of March 31, 2024 and December 31, 2023, respectively1,697,9351,758,558
Oak Street Funding LLC Term Loan for the acquisition of ABC, variable interest of Prime Rate plus 2.0%, maturing September 2029, net of deferred financing costs of $34,029 and $35,649 as of March 31, 2024 and December 31, 2023, respectively2,806,9142,899,409
Oak Street Funding LLC Term Loan for the acquisition of Barra, variable interest of Prime Rate plus 2.5%, maturing May 2032, net of deferred financing costs of $171,406 and $176,762 as of March 31, 2024 and December 31, 2023, respectively5,980,3596,089,580
Long term debt gross12,092,19612,417,737
Less: current portion(1,431,875)(1,390,766)
Long-term debt$10,660,321$11,026,971

Oak Street Funding LLC – Term Loans and Credit Facilities

Fiscal year ending December 31,Maturities of Long-Term Debt
2024 (remainder of year)$1,055,234
20251,552,772
20261,729,160
20271,925,603
20282,106,978
Thereafter3,986,322
Total12,356,069
Less: debt issuance costs(263,873)
Total$12,092,196

Short-Term Financings

The Company has various short-term notes payable for financed items such as insurance premiums and CRM software purchases. These are normally paid in equal installments over a period of twelve months or less and carry interest rates up to 0.0% and 12.75% per annum. As of March 31, 2024 and December 31, 2023, balances outstanding on short-term financings were $12,000 and $56,000, respectively.

NOTE 4. WARRANT LIABILITIES

Series B Warrants

The Series B Warrant liability effective exercise price as of March 31, 2024 was $0.63, and the outstanding balance, inclusive of 16,303 PAW warrants as of March 31, 2024 and December 31, 2023 was $173,660 and $268,993 respectively, presented in the warrant liability account on the condensed consolidated balance sheets. Pursuant to the terms of the Series B Warrants, during the second quarter of 2024, the Series B Warrant exercise price was reduced from $0.63 per share to $0.26 as a result of dilutive issuances of our Common Stock.

For the periods ended March 31, 2024, and 2023, net fair value gains recognized for the Series B Warrants inclusive of the PAW warrants were $95,333 and $4,266,231 respectively, presented in the recognition and change in fair value of warrant liabilities account in the condensed consolidated statements of operations.

NOTE 5. EQUITY

Common Stock

The Company is authorized to issue 2,000,000,000 shares of common stock, $0.086 par value. Each share of issued and outstanding common stock entitles the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.

During the first quarter of 2024, the Company issued 187,614 shares through its ATM program,723,264 pursuant to Abeyance Share conversions and 19,535 shares for equity-based compensation.

As of March 31, 2024 and December 31, 2023, there were 5,692,387 and 4,761,974 shares of common stock outstanding, respectively.

Abeyance Shares

During the quarter ended March 31, 2024 upon request from the institutional investor, the Company converted 723,264 Abeyance Shares into Common Stock, thereby issuing 723,264 shares which resulted in a remaining balance of 1,011,000 of outstanding Abeyance Shares as of March 31, 2024.

During the second quarter of 2024, upon request from the institutional investor, the Company converted the remaining 1,011,000 Abeyance Shares into Common Stock resulting in zero Abeyance Shares outstanding.

Series G Warrants

Pursuant to the terms of the Series G Warrants, during the second quarter of 2024, the Series G Warrant exercise price was reduced from $0.6562 per share to $0.26 as a result of sales of our Common Stock pursuant to the ATM Agreement discussed below.

At Market Program (the “ATM”)

On February 15, 2024, the Company entered into an At Market Issuance Sales Agreement (the “ATM Agreement”) with EF Hutton LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time through the Agent, shares of its Common Stock (the “Shares”), having an aggregate offering price of up to $858,637 (the “ATM Capacity”). Any Shares offered and sold in the offering will be issued pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-275190), which was declared effective by the Securities and Exchange Commission on November 7, 2023, and the related prospectus supplement and accompanying base prospectus relating to the offering of the Shares. Under the Agreement, the Agent may sell Shares by any method permitted by law and deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the “Securities Act”). The offering of Shares pursuant to the Agreement will terminate upon the earlier of (i) the sale of all of the Shares subject to the Agreement, or (ii) the termination of the Agreement by the Agent or the Company, as permitted therein. The Company shall pay to the Agent in cash, upon each sale of Shares pursuant to the ATM Agreement, an amount equal to 3.5% of the gross proceeds from each sale of Shares. The Company will also reimburse the Agent for certain specified expenses in connection with entering into the Agreement.

During the first quarter of 2024 the Company sold 187,614 shares of Common Stock under the ATM Agreement, at a price of $0.6891, receiving proceeds, net of $4,636 in Agent commissions and fees, of $124,649. As of March 31, 2024, the net remaining ATM Capacity was $729,352.

Subsequent to the first quarter of 2024, the Company sold an additional 1,320,829 shares of Common Stock under the ATM Agreement, receiving proceeds, net of $15,905 Agent commissions and fees, of $385,052, resulting in net remaining ATM Capacity of, $328,395.

Equity-based Compensation

Total stock-based compensation expense recorded in general and administrative expenses in the condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 is $18,566 and $43,797, respectively.

NOTE 6. EARNINGS (LOSS) PER SHARE

Basic earnings per common share (“EPS”) applicable to common stockholders is computed by dividing earnings applicable to common stockholders by the weighted-average number of common shares outstanding.

If there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed. Similarly, if the Company has net income but its preferred dividend adjustment made in computing income available to common stockholders results in a net loss available to common stockholders, diluted EPS would be computed in the same manner as basic EPS.

The following calculates basic and diluted EPS:

Three MonthsThree Months
EndedEnded
March 31, 2024March 31, 2023
(Loss) income from continuing operations$(5,346,663)$2,983,861
Net (loss) income continuing operations, numerator, basic computation(5,346,663)2,983,861
Recognition and change in fair value of warrant liabilities-(4,266,231)
Net loss continuing operations, numerator, diluted computation$(5,346,663)$(1,282,370)
Weighted average common shares, basic6,569,0191,553,953
Effect of series B warrants-631,894
Weighted average common shares, dilutive6,569,0192,185,847
Earnings (loss) per common share – basic$(0.81)$1.92
Earnings (loss) per common share – diluted$(0.81)$(0.59)

The reversal of the gain on the change fair value of the Series B warrant liability for the three months March 31, 2023 is included in the numerator of the dilutive EPS calculation to eliminate the effects the warrants as the impact is dilutive.

Additionally, the following are considered anti-dilutive securities excluded from weighted-average shares used to calculate diluted net loss per common share:

For the Three Months Ended
March 31, 2024March 31, 2023
Shares subject to outstanding common stock options10,92810,928
Shares subject to outstanding Series A warrants113,000113,000
Shares subject to outstanding Series B warrants and PAW’s882,970-
Shares subject to outstanding Series F warrants-2,105,264
Shares subject to outstanding Series G warrants4,210,529-
Shares subject to PA Warrants52,63252,632
Shares subject to unvested stock awards8897,709

NOTE 7. LEASES

Operating lease expense for the three months ended March 31, 2024 and 2023 was $104,956 and $161,614, respectively. As of March 31, 2024, the weighted average remaining lease term and weighted average discount rate for the operating leases were 3.92 years and 5.98% respectively.

Future minimum lease payments under these operating leases consists of the following:

Period ending March 31, 2024Operating Lease Obligations
2024$286,739
2025119,388
2026114,572
2027118,009
2028121,550
Thereafter-
Total undiscounted operating lease payments760,258
Less: Imputed interest75,946
Present value of operating lease liabilities$684,312

NOTE 8. COMMITMENTS AND CONTINGENCIES

Legal Contingencies

The Company is subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly andno legal contingencies are accrued as of March 31, 2024 and December 31, 2023. Litigation relating to the insurance brokerage industry is not uncommon. As such the Company, from time to time have been subject to such litigation. No assurances can be given with respect to the extent or outcome of any such litigation in the future.

Earn-out liabilities

The following outlines changes to the Company’s earn-out liability balances for the respective periods ended March 31, 2024 and December 31, 2023:

Fortman · Montana · Altruis · Kush · Barra · Total
Ending balance December 31, 2023$-$159,867$-$-$-$159,867
Changes due to payments------
Changes due to fair value adjustments-47,761---47,761
Payable in Common Stock-(17,628)---(17,628)
Transfers to loans payable, related parties*-(190,000)---(190,000)
Ending balance March 31, 2024$-$-$-$-$-$-
Fortman · Montana · Altruis · Kush · Barra · Total
Ending balance December 31, 2022$667,000$500,001$834,943$147,534$560,000$2,709,478
Payments(1,433,700)(750,001)(929,168)(147,534)-(3,260,403)
Estimate & fair value adjustments1,612,914569,73494,225-(560,000)1,716,873
Payable in Common Stock-(159,867)---(159,867)
Reclass to loans payable, related parties*(846,214)----(846,214)
Ending balance December 31, 2023$-$159,867$-$-$-$159,867
*The Company modified certain contingent earn-out payables by entering into fixed payment arrangements, thus, remaining open balances are reclassified to the loans payable, related parties account on the consolidated balance sheet as of March 31, 2024 and December 31, 2023, respectively.

NOTE 9. RELATED PARTY TRANSACTIONS

The Company, Southwestern Montana Insurance Center, LLC, a Montana limited liability company (the “Subsidiary”), Southwestern Montana Financial Center, Inc., a Montana corporation (the “Seller”), and Julie A. Blockey (the “Holder”, and collectively with the Company, Subsidiary, and Seller, the “Parties”) entered into a purchase agreement on or around April 1, 2019 (the “Purchase Agreement”), whereby the Company purchased the business and certain assets noted within the Purchase Agreement. On September 29, 2023, the Parties entered into a first amendment to the Purchase Agreement (the “First Amendment”). Pursuant to the First Amendment, the Parties agreed to a total remaining balance of $500,000 owed under the Purchase Agreement. In satisfaction of such remaining balance, the Company agreed to issue 174,610 shares of the Company’s restricted common stock, par value $0.086 per share (the “Common Stock”), to the Holder. The First Amendment also stated that if the Nasdaq official closing price of the Common Stock is less than $2.43 on March 29, 2024 (the “Calculation Date”), then a determination of the Make-Up Amount (as defined herein) will be made. The “Make-Up Amount” means $425,000 minus the Blockey Shares Value (174,610 multiplied by the Nasdaq official closing price of the Common Stock on the Calculation Date). The First Amendment further stated that the Company shall pay the Make-Up Amount with a combination of cash and Company shares. Accordingly, on the Calculation Date, a total Make-Up Amount of $367,496 was determined, and as agreed upon by the Parties, will be payable, $190,000 in cash, and the remaining balance via the issuance of 510,485 of the Company’s Common Stock, subsequently issued to the Seller during April, 2024. The $190,000 cash balance was recorded in the current portion of loans payable related parties account in thecondensed consolidated balance sheet as of March 31, 2024.

The following table summarizes the loans payable, related parties current and non-current accounts, and the interest expense related parties account as of and for the three-month period ended March 31, 2024 and December 31, 2023, as presented on the condensed consolidated balance sheets and condensed consolidated statements of operations, respectively:

Current portion of loans payables, related parties · Loans payable, related parties, less current portion · Interest expense, related parties
Related Party · March 31, 2024 · December 31, 2023 · March 31, 2024 · December 31, 2023 · March 31, 2024 · March 31, 2023
Loan to Employee$14,937$25,708$-$-$1,730$1,730
Barra244,556233,504180,837$247,05519,83339,747
Fortman177,183195,741600,078650,47319,046-
Montana190,000-----
Total$626,676$454,953$780,915$897,528$40,609$41,477

NOTE 10. SUBSEQUENT EVENTS

On May 14, 2024, the Company entered into a Stock Exchange Agreement to acquire Spetner Associates (“Spetner”), dated as of May 14, 2024 (the “Stock Exchange Agreement”). Pursuant to the Stock Exchange Agreement, the Company shall: (i) acquire eighty percent (80%) of the issued and outstanding shares of common stock, par value $1.00 per share, of Spetner (the “Spetner Common Stock”) for the amount of $13,714,286 (which shall be paid $8,000,000 in cash, the issuance of certain shares of the Company’s Common Stock, and the Company’s issuance of a promissory note); and (ii) ) have the sole option to acquire the remaining twenty percent (20%) of the Spetner Common Stock for a predetermined amount based on a multiple of EBITDA.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.